Quince Therapeutics, Inc. QNCX 深 沪
已收盘 05-08 16:00:00 美东时间
1.28
-0.020
-1.54%
华盛通- 最 高1.3226
- 今 开1.28
- 成交量 124.67万股
- 最 低 1.20
- 昨 收 1.30
- 总市值 2086.49万
- 52周最高 45.499
- 市盈率 静 --
- 换手率 0.01%
- 52周最低 0.80
- 委 比 -71.66%
- 总股本 1630.07万
- 历史最高 1219.80
- 量 比 1.40
- 振 幅 9.43%
- 历史最低 0.80
- 每 手 1
- 风险率 10.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Quince Therapeutics Appoints June Bray to Board
Quince Therapeutics ( ($QNCX) ) has shared an update. On April 22, 2026, Quince...
04-23 05:33
Why Levi Strauss Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Levi Strauss (LEVI) reported strong Q1 2026 results, raising revenue & earnings guidance. Other pre-market gainers include QNCX, VSME, UCAR, IPW, JEM, AZI, GPUS, AXTI, IPX.
04-08 17:33
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Lunai Bioworks (NASDAQ:LNAI) stock moved upwards by 47.2% to $0.41 dur...
04-08 01:05
Quince Therapeutics Eliminates EIB Debt, Boosts Flexibility
Quince Therapeutics ( ($QNCX) ) has provided an update. On March 27, 2026, Quin...
03-30 22:23
BRIEF-Quince Therapeutics Settles Approximately $16.4 Million Of Debt
BRIEF-Quince Therapeutics Settles Approximately $16.4 Million Of Debt March 30 (Reuters) - Quince Therapeutics Inc QNCX.O : QUINCE THERAPEUTICS SETTLES APPROXIMATELY $16.4 MILLION OF DEBT Source text: ID:nBw9dLCyra Further company coverage: QNCX.O (( Reuters.Briefs@thomsonreuters.com ;))
03-30 22:09
Quince Therapeutics clears $16M EIB debt; shares surge 18%
Quince Therapeutics (QNCX) settled its outstanding ~$16.4M EIB loan at a discounted payoff of $5.5M, reducing its debt balance sheet. CEO & CMO Dirk Thye said the company had settled its EIB debt to a...
03-30 21:45
Quince Therapeutics settles $16M EIB debt for $5.5M payment
Quince Therapeutics settles $16M EIB debt for $5.5M payment Quince Therapeutics settled about $16 million of outstanding European Investment Bank debt via a $5.5 million payment. Obligations under both settlement agreement and underlying loan agreement were fully satisfied and discharged effective i
03-30 20:36
Quince Therapeutics Settles $5.5M Loan Under Its Obligations From European Investment Bank
Quince Therapeutics, Inc. (Nasdaq: QNCX) today announced the successful settlement of the company's outstanding obligations under its loan from the European Investment Bank (EIB) for a payment of $5.5 million. This marks
03-30 20:33
Quince Therapeutics settles $16 million EIB debt in restructuring milestone
Quince Therapeutics settles $16 million EIB debt in restructuring milestone Quince Therapeutics settled European Investment Bank loan obligations of about $16 million through a $5.5 million payment. Debt settlement took effect immediately, discharging obligations under settlement agreement and under
03-30 20:30
Quince Therapeutics Faces Nasdaq Listing Compliance Deficiencies
Quince Therapeutics ( ($QNCX) ) has provided an update. On March 16, 2026, Quin...
03-21 05:26
